1. Home
  2. SPRB vs PT Comparison

SPRB vs PT Comparison

Compare SPRB & PT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRB
  • PT
  • Stock Information
  • Founded
  • SPRB 2014
  • PT 2012
  • Country
  • SPRB United States
  • PT China
  • Employees
  • SPRB N/A
  • PT N/A
  • Industry
  • SPRB Medicinal Chemicals and Botanical Products
  • PT Computer Software: Programming Data Processing
  • Sector
  • SPRB Health Care
  • PT Technology
  • Exchange
  • SPRB Nasdaq
  • PT Nasdaq
  • Market Cap
  • SPRB 15.7M
  • PT 14.8M
  • IPO Year
  • SPRB 2020
  • PT 2018
  • Fundamental
  • Price
  • SPRB $0.36
  • PT $1.00
  • Analyst Decision
  • SPRB Hold
  • PT
  • Analyst Count
  • SPRB 7
  • PT 0
  • Target Price
  • SPRB $2.17
  • PT N/A
  • AVG Volume (30 Days)
  • SPRB 595.7K
  • PT 27.7K
  • Earning Date
  • SPRB 03-12-2025
  • PT 11-08-2024
  • Dividend Yield
  • SPRB N/A
  • PT N/A
  • EPS Growth
  • SPRB N/A
  • PT N/A
  • EPS
  • SPRB N/A
  • PT N/A
  • Revenue
  • SPRB $7,101,000.00
  • PT $4,479,352.00
  • Revenue This Year
  • SPRB N/A
  • PT N/A
  • Revenue Next Year
  • SPRB N/A
  • PT N/A
  • P/E Ratio
  • SPRB N/A
  • PT N/A
  • Revenue Growth
  • SPRB N/A
  • PT N/A
  • 52 Week Low
  • SPRB $0.34
  • PT $0.71
  • 52 Week High
  • SPRB $5.95
  • PT $1.27
  • Technical
  • Relative Strength Index (RSI)
  • SPRB 37.97
  • PT 56.96
  • Support Level
  • SPRB $0.34
  • PT $0.95
  • Resistance Level
  • SPRB $0.39
  • PT $1.02
  • Average True Range (ATR)
  • SPRB 0.03
  • PT 0.05
  • MACD
  • SPRB 0.00
  • PT 0.01
  • Stochastic Oscillator
  • SPRB 20.73
  • PT 82.35

About SPRB Spruce Biosciences Inc.

Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The company is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer markedly improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH).

About PT Pintec Technology Holdings Limited

Pintec Technology Holdings Ltd is a technology platform that provides financial services in China in terms of loan volume facilitated. The company connects business partners and financial partners on its open platform and enables them to provide financial services to end-users. Its products include installment loans, personal loans, wealth management, insurance brokerage, SME loans, and others. The company generates its revenue from technical service fees also by providing financing for these borrowers and earn installment service fees, They earn wealth management services fees and commission on financial products.

Share on Social Networks: